Healthcare Finance News October 4, 2023
Insurers are now precluded by federal regulation from implementing copay accumulators for drugs that lack generic equivalents.
A federal judge has struck down a Trump administration rule that allowed health insurers to exclude drug manufacturer co-pay assistance towards a beneficiary’s out-of-pocket costs.
Under the Trump rule, these “copay accumulator” policies meant patients generally paid more out of pocket for their prescription drugs.
The case was brought against the U.S. Department of Health and Human Services by the HIV+Hepatitis Policy Institute, Diabetes Leadership Council, Diabetes Patient Advocacy Coalition, and three patients who depend on co-pay assistance and whose insurers implemented co-pay accumulator policies.
Under these co-pay accumulator policies, patients are still able to use manufacturer discounts to pay for medications, but...
Today's Sponsors
Today's Sponsor